1. Home
  2. RPGL vs ARTL Comparison

RPGL vs ARTL Comparison

Compare RPGL & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Republic Power Group Limited Class A Ordinary Shares

RPGL

Republic Power Group Limited Class A Ordinary Shares

N/A

Current Price

$26.20

Market Cap

2.3M

Sector

Technology

ML Signal

N/A

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$3.83

Market Cap

2.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RPGL
ARTL
Founded
2015
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.5M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
RPGL
ARTL
Price
$26.20
$3.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
129.7K
★ 1.3M
Earning Date
07-10-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.40
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.52
52 Week High
$14.24
$19.91

Technical Indicators

Market Signals
Indicator
RPGL
ARTL
Relative Strength Index (RSI) 90.52 49.69
Support Level $0.89 $3.20
Resistance Level N/A $6.81
Average True Range (ATR) 0.87 1.30
MACD 1.72 -0.25
Stochastic Oscillator 81.27 4.89

Price Performance

Historical Comparison
RPGL
ARTL

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: